Literature DB >> 11591507

The discovery of sulfonylated dipeptides as potent VLA-4 antagonists.

W K Hagmann1, P L Durette, T Lanza, N J Kevin, S E de Laszlo, I E Kopka, D Young, P A Magriotis, B Li, L S Lin, G Yang, T Kamenecka, L L Chang, J Wilson, M MacCoss, S G Mills, G Van Riper, E McCauley, L A Egger, U Kidambi, K Lyons, S Vincent, R Stearns, A Colletti, J Teffera, S Tong, J Fenyk-Melody, K Owens, D Levorse, P Kim, J A Schmidt, R A Mumford.   

Abstract

Directed screening of a carboxylic acid-containing combinatorial library led to the discovery of potent inhibitors of the integrin VLA-4. Subsequent optimization by solid-phase synthesis afforded a series of sulfonylated dipeptide inhibitors with structural components that when combined in a single hybrid molecule gave a sub-nanomolar inhibitor as a lead for medicinal chemistry. Preliminary metabolic studies led to the discovery of substituted biphenyl derivatives with low picomolar activities. SAR and pharmacokinetic characterization of this series are presented.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591507     DOI: 10.1016/s0960-894x(01)00544-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

Review 1.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

2.  Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors.

Authors:  Nilgun Isik Reed; You-Zhi Tang; Joel McIntosh; Yibing Wu; Kathleen S Molnar; Annafelicia Civitavecchia; Dean Sheppard; William F DeGrado; Hyunil Jo
Journal:  ACS Med Chem Lett       Date:  2016-08-30       Impact factor: 4.345

3.  Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.

Authors:  Darja Karpova; Michael P Rettig; Julie Ritchey; Daniel Cancilla; Stephanie Christ; Leah Gehrs; Ezhilarasi Chendamarai; Moses O Evbuomwan; Matthew Holt; Jingzhu Zhang; Grazia Abou-Ezzi; Hamza Celik; Eliza Wiercinska; Wei Yang; Feng Gao; Linda G Eissenberg; Richard F Heier; Stacy D Arnett; Marvin J Meyers; Michael J Prinsen; David W Griggs; Andreas Trumpp; Peter G Ruminski; Dwight M Morrow; Halvard B Bonig; Daniel C Link; John F DiPersio
Journal:  J Clin Invest       Date:  2019-05-14       Impact factor: 14.808

4.  Bioisostere Effects on the EPSA of Common Permeability-Limiting Groups.

Authors:  Andrew K Ecker; Dorothy A Levorse; Daniel A Victor; Matthew J Mitcheltree
Journal:  ACS Med Chem Lett       Date:  2022-05-23       Impact factor: 4.632

5.  Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism.

Authors:  Meredith W Miller; Sandeep Basra; Daniel W Kulp; Paul C Billings; Sungwook Choi; Mary Pat Beavers; Owen J T McCarty; Zhiying Zou; Mark L Kahn; Joel S Bennett; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

6.  Small molecule inhibitors of integrin alpha2beta1.

Authors:  Sungwook Choi; Gaston Vilaire; Cezary Marcinkiewicz; Jeffrey D Winkler; Joel S Bennett; William F DeGrado
Journal:  J Med Chem       Date:  2007-10-04       Impact factor: 7.446

Review 7.  Emerging therapeutic opportunities for integrin inhibitors.

Authors:  R J Slack; S J F Macdonald; J A Roper; R G Jenkins; R J D Hatley
Journal:  Nat Rev Drug Discov       Date:  2021-09-17       Impact factor: 84.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.